Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002111144 | SCV002384116 | likely benign | not provided | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002111144 | SCV002496319 | likely benign | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003015235 | SCV003685258 | likely benign | Inborn genetic diseases | 2022-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003458829 | SCV004179628 | likely benign | Developmental and epileptic encephalopathy, 69 | 2023-04-11 | criteria provided, single submitter | clinical testing |